Browse by People

Collapse authors list.
Negredo, Eugenia, Back, David, Blanco, José-Ramón, Blanco, Julià, Erlandson, Kristine M, Garolera, Maite, Guaraldi, Giovanni, Mallon, Patrick, Moltó, José, Serra, José Antonio et al (show 1 more authors) and Clotet, Bonaventura (2017) Aging in HIV-Infected Subjects: A New Scenario and a New View. BioMed research international, 2017. p. 5897298.

Olagunju, Adeniyi, Bolaji, Oluseye, Amara, Alieu, Waitt, Catriona, Else, Laura, Adejuyigbe, Ebunoluwa, Siccardi, Marco, Back, David, Khoo, Saye and Owen, Andrew (2015) Breast milk pharmacokinetics of efavirenz and breastfed infants' exposure in genetically-defined subgroups of mother-infant pairs: an observational study. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Collapse authors list.
Fox, Julie, Tiraboschi, Juan M, Herrera, Carolina ORCID: 0000-0003-3701-752X, Else, Laura, Egan, Deirdre, Dickinson, Laura ORCID: 0000-0001-5557-9396, Jackson, Akil ORCID: 0000-0002-4574-544X, Olejniczak, Natalia, Back, David, Khoo, Saye ORCID: 0000-0002-2769-0967 et al (show 2 more authors) , Shattock, Robin and Boffito, Marta ORCID: 0000-0002-2213-1103 (2016) Brief Report: Pharmacokinetic/Pharmacodynamic Investigation of Single-Dose Oral Maraviroc in the Context of HIV-1 Pre-exposure Prophylaxis. Journal of acquired immune deficiency syndromes (1999), 73 (3). pp. 252-257.

Back, David, Marzolini, Catia, Hodge, Catherine, Marra, Fiona ORCID: 0000-0003-1326-1149, Boyle, Alison, Gibbons, Sara, Burger, David and Khoo, Saye (2021) COVID-19 treatment in patients with comorbidities: Awareness of drug-drug interactions. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 87 (1). pp. 212-213.

Collapse authors list.
Marra, Fiona ORCID: 0000-0003-1326-1149, zu Siederdissen, Christoph Hoener, Khoo, Saye ORCID: 0000-0002-2769-0967, Back, David, Schlag, Michael, Ouwerkerk-Mahadevan, Sivi, Bicer, Ceyhun, Lonjon-Domanec, Isabelle, Jessner, Wolfgang, Beumont-Mauviel, Maria et al (show 2 more authors) , Kalmeijer, Ronald and Cornberg, Markus (2018) Clinical impact of pharmacokinetic interactions between the HCV protease inhibitor simeprevir and frequently used concomitant medications. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 84 (5). pp. 961-971.

Marzolini, Catia, Gibbons, Sara, Khoo, Saye ORCID: 0000-0002-2769-0967 and Back, David (2016) Cobicistat versus ritonavir boosting and differences in the drug-drug interaction profiles with co-medications. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 71 (7). pp. 1755-1758.

Collapse authors list.
Dickinson, Laura ORCID: 0000-0001-5557-9396, Amin, Janaki, Else, Laura, Boffito, Marta, Egan, Deirdre, Owen, Andrew ORCID: 0000-0002-9819-7651, Khoo, Saye ORCID: 0000-0002-2769-0967, Back, David, Orrell, Catherine, Clarke, Amanda et al (show 6 more authors) , Losso, Marcelo, Phanuphak, Praphan, Carey, Dianne, Cooper, David A, Emery, Sean and Puls, Rebekah (2016) Comprehensive Pharmacokinetic, Pharmacodynamic and Pharmacogenetic Evaluation of Once-Daily Efavirenz 400 and 600 mg in Treatment-Naive HIV-Infected Patients at 96 Weeks: Results of the ENCORE1 Study. CLINICAL PHARMACOKINETICS, 55 (7). pp. 861-873.

Mellor, Claire Developing safer HIV drugs: elucidating the mechanistic pathway of Tenofovir-induced cytotoxicity via mitochondrial dysfunction. Doctor of Philosophy thesis, University of Liverpool.

Collapse authors list.
Olagunju, Adeniyi ORCID: 0000-0002-6588-5749, Bolaji, Oluseye O, Amara, Alieu ORCID: 0000-0002-1137-2948, Waitt, Catriona ORCID: 0000-0003-0134-5855, Else, Laura, Soyinka, Julius, Adeagbo, Babatunde, Adejuyigbe, Ebunoluwa, Siccardi, Marco ORCID: 0000-0002-3539-7867, Back, David et al (show 2 more authors) , Owen, Andrew ORCID: 0000-0002-9819-7651 and Khoo, Saye ORCID: 0000-0002-2769-0967 (2015) Development, validation and clinical application of a novel method for the quantification of efavirenz in dried breast milk spots using LC-MS/MS. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 70 (2). pp. 555-561.

Elliot, Emilie, Amara, Alieu ORCID: 0000-0002-1137-2948, Jackson, Akil ORCID: 0000-0002-4574-544X, Moyle, Graeme, Else, Laura, Khoo, Saye ORCID: 0000-0002-2769-0967, Back, David, Owen, Andrew ORCID: 0000-0002-9819-7651 and Boffito, Marta (2016) Dolutegravir and elvitegravir plasma concentrations following cessation of drug intake. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 71 (4). pp. 1031-1036.

Hodge, Daryl ORCID: 0000-0003-2288-7020, Marra, Fiona ORCID: 0000-0003-1326-1149, Marzolini, Catia, Boyle, Alison, Gibbons, Sara, Siccardi, Marco ORCID: 0000-0002-3539-7867, Burger, David, Back, David and Khoo, Saye (2020) Drug interactions: a review of the unseen danger of experimental COVID-19 therapies. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 75 (12). pp. 3417-3424.

Collapse authors list.
Back, David, Belperio, Pamela, Bondin, Mark, Negro, Francesco, Talal, Andrew H, Park, Caroline, Zhang, ZhenZhen, Pinsky, Brett, Crown, Eric, Mensa, Federico J et al (show 1 more authors) and Marra, Fiona ORCID: 0000-0003-1326-1149 (2019) Efficacy and safety of glecaprevir/pibrentasvir in patients with chronic HCV infection and psychiatric disorders: An integrated analysis. JOURNAL OF VIRAL HEPATITIS, 26 (8). pp. 951-960.

Schulte, Benjamin, Wuebbolding, Maximilian, Marra, Fiona ORCID: 0000-0003-1326-1149, Port, Kerstin, Manns, Michael P, Back, David, Cornberg, Markus, Stichtenoth, Dirk O, zu Siederdissen, Christoph Hoener and Maasoumy, Benjamin (2020) Frequency of Potential Drug-Drug Interactions in the Changing Field of HCV Therapy. OPEN FORUM INFECTIOUS DISEASES, 7 (2). ofaa040-.

Collapse authors list.
McGowan, Ian, Dezzutti, Charlene S, Siegel, Aaron, Engstrom, Jarret, Nikiforov, Alexiy, Duffill, Kathryn, Shetler, Cory, Richardson-Harman, Nicola, Abebe, Kaleab, Back, David et al (show 12 more authors) , Else, Laura, Egan, Deidre, Khoo, Saye ORCID: 0000-0002-2769-0967, Egan, James E, Stall, Ronald, Williams, Peter E, Rehman, Khaleel K, Adler, Amy, Brand, Rhonda M, Chen, Beatrice, Achilles, Sharon and Cranston, Ross D (2016) Long-acting rilpivirine as potential pre-exposure prophylaxis for HIV-1 prevention (the MWRI-01 study): an open-label, phase 1, compartmental, pharmacokinetic and pharmacodynamic assessment. LANCET HIV, 3 (12). E569-E578.

Collapse authors list.
Cranston, Ross D, Dezzutti, Charlene S, Siegel, Aaron, Engstrom, Jarret, Shetler, Cory, Richardson-Harman, Nicola, Abebe, Kaleab Z, Back, David, Else, Laura, Egan, Deidre et al (show 7 more authors) , Khoo, Saye ORCID: 0000-0002-2769-0967, Egan, James E, Stall, Ronald, Williams, Peter, Brand, Rhonda M, Parikh, Urvi M and McGowan, Ian (2019) A Multiple Dose Phase 1 Assessment of Rilpivirine Long Acting in a Model of Preexposure Prophylaxis Against HIV. AIDS RESEARCH AND HUMAN RETROVIRUSES, 35 (9). pp. 794-804.

Collapse authors list.
Larrey, Dominique, Puoti, Massimo, Piekarska, Anna, Back, David, Marra, Fiona ORCID: 0000-0003-1326-1149, Bondin, Mark, Raheja, Ritu, Zhang, Zhenzhen, Kalluri, Hari V, Marcinak, John et al (show 1 more authors) and Roncero, Carlos (2020) POLYPHARMACY IN HCV-INFECTED PATIENTS WHO USE DRUGS TREATED WITH GLECAPREVIR/PIBRENTASVIR: A REAL-WORLD ANALYSIS FROM 9 COUNTRIES. .

Collapse authors list.
Dickinson, Laura, Amin, J, Else, Laura, Boffito, M, Egan, Deirdre, Owen, Andrew ORCID: 0000-0002-9819-7651, Khoo, Saye ORCID: 0000-0002-2769-0967, Back, David, Orrell, C, Clarke, A et al (show 6 more authors) , Losso, M, Phanuphak, P, Carey, D, Cooper, DA, Emery, S and Puls, R (2015) Pharmacokinetic and Pharmacodynamic Comparison of Once-Daily Efavirenz (400 mg vs. 600 mg) in Treatment-Naïve HIV-Infected Patients: Results of the ENCORE1 Study. Clinical pharmacology and therapeutics, 98 (4). pp. 406-416.

Collapse authors list.
Fox, Julie, Tiraboschi, Juan M, Herrera, Carolina, Else, Laura, Egan, Deirdre, Dickinson, Laura ORCID: 0000-0001-5557-9396, Jackson, Akil, Olejniczak, Natalia, Back, David, Khoo, Saye ORCID: 0000-0002-2769-0967 et al (show 2 more authors) , Shattock, Robin and Boffito, Marta (2016) Pharmacokinetic/Pharmacodynamic Investigation of Single-Dose Oral Maraviroc in the Context of HIV-1 Pre-exposure Prophylaxis. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 73 (3). pp. 252-257.

Jackson, Akil ORCID: 0000-0002-4574-544X, Else, Laura, Higgs, Christopher, Karolia, Zeenat, Khoo, Saye ORCID: 0000-0002-2769-0967, Back, David, Devitt, Emma, Pozniak, Anton and Boffito, Marta (2018) Pharmacokinetics and pharmacodynamics of the nucleoside sparing dual regimen containing rilpivirine plus darunavir/ritonavir in treatment-naive HIV-1-infected individuals. HIV CLINICAL TRIALS, 19 (1). pp. 31-37.

Marzolini, Catia, Rajoli, Rajith ORCID: 0000-0002-6015-5712, Battegay, Manuel, Elzi, Luigia, Back, David and Siccardi, Marco ORCID: 0000-0002-3539-7867 (2017) Physiologically Based Pharmacokinetic Modeling to Predict Drug-Drug Interactions with Efavirenz Involving Simultaneous Inducing and Inhibitory Effects on Cytochromes. CLINICAL PHARMACOKINETICS, 56 (4). pp. 409-420.

Collapse authors list.
Dickinson, Laura ORCID: 0000-0001-5557-9396, Yapa, H Manisha, Jackson, Akil ORCID: 0000-0002-4574-544X, Moyle, Graeme, Else, Laura, Amara, Alieu ORCID: 0000-0002-1137-2948, Khoo, Saye ORCID: 0000-0002-2769-0967, Back, David, Karolia, Zeenat, Higgs, Chris et al (show 1 more authors) and Boffito, Marta (2015) Plasma Tenofovir, Emtricitabine, and Rilpivirine and Intracellular Tenofovir Diphosphate and Emtricitabine Triphosphate Pharmacokinetics following Drug Intake Cessation. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 59 (10). pp. 6080-6086.

Dickinson, Laura ORCID: 0000-0001-5557-9396, Bracchi, Margherita, Elliot, Emilie, Else, Laura, Khoo, Saye ORCID: 0000-0002-2769-0967, Back, David, Nelson, Mark and Boffito, Marta (2016) Population pharmacokinetics (PK) of dolutegravir (DTG) alone and following treatment switch. .

Rajoli, Rajith KR ORCID: 0000-0002-6015-5712, Curley, Paul ORCID: 0000-0003-4596-2708, Chiong, Justin ORCID: 0000-0001-8063-6399, Back, David, Flexner, Charles, Owen, Andrew ORCID: 0000-0002-9819-7651 and Siccardi, Marco ORCID: 0000-0002-3539-7867 (2019) Predicting Drug-Drug Interactions Between Rifampicin and Long-Acting Cabotegravir and Rilpivirine Using Physiologically Based Pharmacokinetic Modeling. JOURNAL OF INFECTIOUS DISEASES, 219 (11). pp. 1735-1742.

Collapse authors list.
Arshad, Usman ORCID: 0000-0003-1586-1885, Pertinez, Henry, Box, Helen, Tatham, Lee, Rajoli, Rajith KR ORCID: 0000-0002-6015-5712, Curley, Paul ORCID: 0000-0003-4596-2708, Neary, Megan, Sharp, Joanne, Liptrott, Neill ORCID: 0000-0002-5980-8966, Valentijn, Anthony et al (show 11 more authors) , David, Christopher ORCID: 0000-0001-8504-2354, Rannard, Steve ORCID: 0000-0002-6946-1097, O’Neill, Paul, Aljayyoussi, Ghaith, Pennington, Shaun, Ward, Stephen, Back, David, Khoo, Saye, Bray, Patrick, Biagini, Giancarlo ORCID: 0000-0001-6356-6595 and Owen, Andrew ORCID: 0000-0002-9819-7651 (2020) Prioritisation of potential anti-SARS-CoV-2 drug repurposing opportunities based on ability to achieve adequate plasma and target site concentrations derived from their established human pharmacokinetics. Clinical Pharmacology and Therapeutics.

Collapse authors list.
Ferenci, Peter, Bourgeois, Stefan, Buggisch, Peter, Norris, Suzanne, Curescu, Manuela, Larrey, Dominique, Marra, Fiona ORCID: 0000-0003-1326-1149, Kleine, Henning, Dorr, Patrick, Charafeddine, Mariem et al (show 4 more authors) , Crown, Eric, Bondin, Mark, Back, David and Flisiak, Robert (2019) Real-world safety and effectiveness of ombitasvir/paritaprevir/ritonavir±dasabuvir±ribavirin in hepatitis C virus genotype 1-and 4-infected patients with diverse comorbidities and comedications: A pooled analysis of post-marketing observational studies from 13 countries. JOURNAL OF VIRAL HEPATITIS, 26 (6). pp. 685-696.

Collapse authors list.
Marra, Fiona ORCID: 0000-0003-1326-1149, Smolders, Elise J, El-Sherif, Omar, Boyle, Alison, Davidson, Katherine, Sommerville, Andrew J, Marzolini, Catia, Siccardi, Marco ORCID: 0000-0002-3539-7867, Burger, David, Gibbons, Sara et al (show 2 more authors) , Khoo, Saye and Back, David (2021) Recommendations for Dosing of Repurposed COVID-19 Medications in Patients with Renal and Hepatic Impairment. DRUGS IN R&D, 21 (1). pp. 9-27.

Collapse authors list.
Penman, Sophie L ORCID: 0000-0001-5326-1675, Kiy, Robyn T ORCID: 0000-0001-7960-7283, Jensen, Rebecca L ORCID: 0000-0003-1134-2869, Beoku‐Betts, Christopher, Alfirevic, Ana ORCID: 0000-0002-2801-9817, Back, David, Khoo, Saye H, Owen, Andrew ORCID: 0000-0002-9819-7651, Pirmohamed, Munir ORCID: 0000-0002-7534-7266, Park, B Kevin ORCID: 0000-0001-8384-824X et al (show 3 more authors) , Meng, Xiaoli ORCID: 0000-0002-7774-2075, Goldring, Christopher E and Chadwick, Amy E ORCID: 0000-0002-7399-8655 (2020) Safety perspectives on presently considered drugs for the treatment of COVID‐19. British Journal of Pharmacology, 177 (19). pp. 4353-4374.

Dickinson, Laura ORCID: 0000-0001-5557-9396, Winston, Alan, Boffito, Marta, Khoo, Saye ORCID: 0000-0002-2769-0967, Back, David and Siccardi, Marco ORCID: 0000-0002-3539-7867 (2016) Simulation of the impact of rifampicin on once-daily darunavir/ritonavir pharmacokinetics and dose adjustment strategies: a population pharmacokinetic approach. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 71 (4). pp. 1041-1045.

Dickinson, Laura ORCID: 0000-0001-5557-9396, Jackson, Akil ORCID: 0000-0002-4574-544X, Garvey, L, Watson, Victoria, Khoo, Saye ORCID: 0000-0002-2769-0967, Boffito, M, Davies, Geraint ORCID: 0000-0002-3819-490X and Back, David (2012) Simultaneous population pharmacokinetic modelling of darunavir and ritonavir Once daily in HIV-infected patients: evaluation of lower ritonavir dose. Journal of the International AIDS Society, 15 (4).

Else, Laura, Back, David, Khoo, Saye H ORCID: 0000-0002-2769-0967 and Merry, Concepta (2015) Steady-state pharmacokinetics of rilpivirine under different meal conditions in HIV-1-infected Ugandan adults. The Journal of Antimicrobial Chemotherapy, 70 (5). pp. 1482-1486.

Back, David ORCID: 0000-0002-7381-4799 and Marzolini, Catia (2020) The challenge of HIV treatment in an era of polypharmacy. Journal of the International AIDS Society, 23 (2). e25449-.

Watson, Victoria The clinical pharmacology of Human Immunodeficiency Virus (HIV) therapy failure. Doctor of Philosophy thesis, University of Liverpool.

Penchala, Sujan Dilly, Fawcett, Sandra, Else, Laura, Egan, Deirdre, Amara, Alieu ORCID: 0000-0002-1137-2948, Elliot, Emilie, Challenger, Elizabeth ORCID: 0000-0002-8978-6067, Back, David, Boffito, Marta and Khoo, Saye ORCID: 0000-0002-2769-0967 (2016) The development and application of a novel LC-MS/MS method for the measurement of Dolutegravir, Elvitegravir and Cobicistat in human plasma. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 1027. pp. 174-180.